The next generation in
medical-grade fibers, RxFibron HT (US Pat. 10,835,645) is the first
medical-grade PET to exhibit high-tenacity properties without
compromising strength for developing low-profile
devices.
Windsor, CA - RxFiber, the first manufacturer dedicated
solely to engineering medical-grade fibers for the medical device
industry, has developed and commercially released its latest
product, RxFibron HT (US Pat. 10,835,645), a high-tenacity PET (Polyester)
biomaterial for medical device applications. As an innovative
alternative to UHMWPE and regular Polyester, RxFibron HT (US Pat. 10,835,645) features
several advantages over current market PETs including durability,
high strength, thermal melt properties for ease of manufacturing,
and custom size variations suitable for creating lower-profile
devices.
The revolutionary RxFibron HT (US Pat. 10,835,645)is the first commercially
available high-tenacity, medical-grade PET biomaterial that can be
used to create next-generation implantable devices, such as
sutures, composites, and more for applications such as
endovascular, vascular, and orthopedics.
"Engineers will have the ability to develop lower-profile
devices while maintaining the strength and integrity of the
device," says Robert Torgerson, Founder and President of RxFiber
and leading expert in biomaterial medical device design. "In lieu
of UHMWPE, RxFibron HT (US Pat. 10,835,645) can meet the criteria of having substantial
strength, biocompatibility, lower profile (smaller denier yarn),
and custom size fibers. High-tenacity PET fibers are a substantial
upgrade from regular Polyester and will yield innovative,
next-generation products."
With a tenacity of greater than 6.5, RxFibron HT (US Pat. 10,835,645) is
more than double the strength of regular PET found in current
devices on the market, which allows device manufacturers to reduce
device thickness in fabric or structure while maintaining strength
and flexibility by using RxFibron HT's smaller denier yarn.
"Physicians are looking for smaller and smaller delivery systems
to deliver the device in a transcatheter application which
mitigates trauma to the patient," says Martin W. King, PhD,
Professor of Biotextiles & Textile Technology, North Carolina
State University. "RxFibron HT (US Pat. 10,835,645) is the first
commercially released product of its kind to deliver this
lower-profile product potential."
To meet the criteria of medical device companies, RxFibron
HT (US Pat. 10,835,645) is custom-made with traceable quality systems to
meet the specifications of next-generation, lower-profile
devices.
RxFiber is hosting a webinar on Thursday, October 24, 2013 at
10:30 am PDT, Next Gen Biomaterials: Creating lower profiles
devices using high-tenacity PET and alternatives to UHMWPE and
regular Polyester.
About RxFiber, LLC
RxFiber manufactures a wide variety of next-generation,
high-quality, innovative and custom-designed medical-grade yarn and
fiber solutions. As the leading expert in producing multifilament
fine denier, high-tenacity fibers with both absorbable and
non-absorbable qualities, RxFiber works with customers' medical
device needs to provide textile solutions that best match the
specifications required to produce reliable and verifiable
products. The company develops custom yarns and can replace aging
yarn inventory with quality yarn in smaller quantities that meet
production specifications. RxFiber also provides small custom fiber
runs that can be fully integrated with product specifications and
can coordinate and consult on the testing and conversion process.
RxFiber's technical experts can also consult on weaving, knitting
and braiding solutions that are best aligned with the device
specifications. For more information or to request a sample, call
866.308.6025 or visit www.RXFiber.com.
Continue reading...